Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Cefaclor Anhydrous. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 1.00 |
| ▸ | MAPT | P10636 | 7/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 6/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 1.00 |
| ▸ | MEN1 | O00255 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 4/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 1.00 |
| ▸ | SLC15A2 | Q16348 | 3/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 1/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.77 |
| ▸ | BLM | P54132 | 1/20 | 0.77 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.77 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cefaclor Anhydrous SCHEMBL33540 | 1.00 | ALDH1A1 (1.00) | ALDH1A1HSD17B10MAPTKMT2AKDM4E | |
| Cefaclor Anhydrous SCHEMBL8626211 | 1.00 | ALDH1A1 (1.00) | ALDH1A1HSD17B10MAPTKMT2AKDM4E | |
| Cefaclor Anhydrous SCHEMBL8524989 | 1.00 | ALDH1A1 (1.00) | ALDH1A1HSD17B10MAPTKMT2AKDM4E | |
| Cefaclor Anhydrous SCHEMBL8943624 | 1.00 | ALDH1A1 (1.00) | ALDH1A1HSD17B10MAPTKMT2AKDM4E | |
| Cefaclor Anhydrous SCHEMBL6155629 | 1.00 | ALDH1A1 (1.00) | ALDH1A1HSD17B10MAPTKMT2AKDM4E | |
| Cefaclor Anhydrous SCHEMBL16072812 | 1.00 | ALDH1A1 (1.00) | ALDH1A1HSD17B10MAPTKMT2AKDM4E | |
| Cefaclor Anhydrous SCHEMBL8478823 | 1.00 | ALDH1A1 (1.00) | ALDH1A1HSD17B10MAPTKMT2AKDM4E | |
| Cefaclor Anhydrous SCHEMBL1006419 | 1.00 | ALDH1A1 (1.00) | ALDH1A1HSD17B10MAPTKMT2AKDM4E | |
| Cefaclor Anhydrous SCHEMBL8626208 | 1.00 | ALDH1A1 (1.00) | ALDH1A1HSD17B10MAPTKMT2AKDM4E | |
| Cefaclor Anhydrous SCHEMBL27281884 | 1.00 | ALDH1A1 (1.00) | ALDH1A1HSD17B10MAPTKMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2588 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260027140-A1 | COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA | ATOPIC MEDICAL INC (US) | 2026-01-29 | — | — | US | claimed |
| US-12465623-B2 | Use of parasites and extracellular vesicles obtained from parasites in cancer treatment | YEDITEPE UNIVERSITESI (TR) | 2025-11-11 | — | — | US | claimed |
| EP-3965808-B1 | USE OF PARASITES AND EXTRACELLULAR VESICLES OBTAINED FROM PARASITES IN CANCER TREATMENT | UNIV YEDITEPE (TR) | 2025-09-03 | — | — | EP | claimed |
| US-12371429-B2 | Antibiotic resistance-modifying tricyclic heteroaryl compounds and uses thereof | RECREO PHARMACEUTICALS LLC (US) | 2025-07-29 | — | — | US | claimed |
| EP-4338799-A2 | TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY | Regents of the University of Minnesota (US) | 2024-03-20 | — | — | EP | claimed |
| US-20240082370-A1 | SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION | THERIVA BIOLOGICS, INC. | 2024-03-14 | — | — | US | claimed |
| US-20230414584-A1 | ADMINISTRATION OF ANTIBIOTIC COMPOUNDS FOR THE TREATMENT OF STREPTOCOCCAL INFECTIONS FOR THE TREATMENT OF PSORIASIS | CENTRE FOR DIGESTIVE DISEASES (AU) | 2023-12-28 | — | — | US | claimed |
| EP-3529359-B1 | TUMOR INFILTRATING LYMPHOCYTES FOR USE IN THERAPY | UNIV MINNESOTA (US) | 2023-12-13 | — | — | EP | claimed |
| CN-116650492-A | Administration of antibiotic compounds for the treatment of streptococcal infections to treat psoriasis | 消化系统疾病中心 | 2023-08-29 | — | — | CN | claimed |
| US-20220226393-A1 | USE OF PARASITES AND EXTRACELLULAR VESICLES OBTAINED FROM PARASITES IN CANCER TREATMENT | YEDITEPE UNIVERSITESI (TR) | 2022-07-21 | — | — | US | claimed |
| EP-1244471-A1 | LIQUID COMPOSITION OF BIODEGRADABLE BLOCK COPOLYMER FOR DRUG DELIVERY SYSTEM AND PROCESS FOR THE PREPARATION THEREOF | Samyang Corporation (KR) | 2002-10-02 | — | — | EP | claimed |
| US-20020042394-A1 | Cobalamin compounds useful as antibiotic agents and as imaging agents | HOGENKAMP HENRICUS P C (US) | 2002-04-11 | — | — | US | claimed |
| WO-2001092288-A2 | COBALAMIN COMPOUNDS USEFUL AS ANTIBIOTIC AGENTS AND AS IMAGING AGENTS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2001-12-06 | — | — | WO | claimed |
| WO-2001045742-A1 | LIQUID COMPOSITION OF BIODEGRADABLE BLOCK COPOLYMER FOR DRUG DELIVERY SYSTEM AND PROCESS FOR THE PREPARATION THEREOF | SAMYANG CORPORATION (KR) | 2001-06-28 | — | — | WO | claimed |
| US-6060268-A | PROVIDES A HIGHER SYNTHESIS/HYDROLYSIS RATIO; FOR PRODUCTION OF BETA-LACTAM DERIVATIVES SUCH AS CEPHALOSPORINS AND PENICILLINS BY REACTING AN AMINO BETA-LACTAM WITH AN ACYLATING AGENT IN THE PRESENCE OF THE IMMOBILIZED ENZYME | GIST-BROCADES B.V. (NL) | 2000-05-09 | — | — | US | claimed |
| EP-0839192-A1 | AN IMPROVED IMMOBILIZED PENICILLIN G ACYLASE | GIST-BROCADES B.V. (NL) | 1998-05-06 | — | — | EP | claimed |
| WO-1997004086-A1 | AN IMPROVED IMMOBILIZED PENICILLIN G ACYLASE | GIST-BROCADES B.V. (NL) | 1997-02-06 | — | — | WO | claimed |
| US-5354556-A | Microparticles in form of micromatrix with active ingredient uniformly distributed in nontoxic polymer suspended in aqueous vehicle containing substance which inhibits release during storage | ELAN CORPORATION, PLC (IE) | 1994-10-11 | — | — | US | claimed |
| EP-0280571-B1 | SUSTAINED RELEASE MATRIX FORMULATIONS | ELI LILLY AND COMPANY (US) | 1993-08-04 | — | — | EP | claimed |
| US-4952402-A | EDIBLE TASTE-MASKED DRUGS; MICROMATRIX ACTIVE MATERIAL COATED WITH NONTOXIC POLYMER; LIQUIDS; TABLETS | ELAN CORPORATION, P.L.C. (IE) | 1990-08-28 | — | — | US | claimed |